tamfinder.ai

Tamfinder market filing

Global

Aug 31, 2026

VC-SCALE

Calculate the TAM of a business and let me know if the idea is bootscrapable or VC scalable. here's the idea: i am designing a wearable tracking device for people with dementia, particularly to help families and caregivers keep them safe when they wander or become disoriented. the device is designe

TAM // TOTAL ADDRESSABLE MARKET

Low confidence

$1.5B to $6.6B

SAM // SERVICEABLE ADDRESSABLE MARKET

Low confidence

$180M to $530M

SOM 3YR // SERVICEABLE OBTAINABLE MARKET

$0M

Real market, real recurring revenue, but the distribution moat is missing

The dementia tracking space clears the vc_scale bar: conservative TAM of $1.5B, a credible SOM path above $10M by year three, and a structurally recurring subscription model at 50-plus percent gross margins. The market is fragmented enough that no single incumbent is a ceiling. What will likely kill your pitch is the CAC problem you have not solved: the buyer is an exhausted family caregiver who needs the device recommended by a neurologist, a memory-care facility, or an insurer, not found via a Google ad. AngelSense already has that institutional relationship at $35 per month, and your pitch deck will need to show a reimbursement or channel partnership path before any serious investor treats your SOM numbers as real.

Key risk

Without a clinical or institutional referral channel, CAC will exceed first-year subscription revenue.

TAM // TOTAL ADDRESSABLE MARKET

Low confidence

$1.5B to $6.6B

stated: $1.5B

Analyst estimates span $450M to $6.47B in 2024; bottom-up yields $6.6B; methods diverge by more than 3x.

Top-down analysts disagree on scope (GPS-only vs. Multi-modal); bottom-up applies full wandering population at year-one ARPU, overstating near-term reachability. Conservative bound taken as display value.

SAM // SERVICEABLE ADDRESSABLE MARKET

Low confidence

$180M to $530M

stated: $180M

Top-down and bottom-up SAM estimates diverge by more than 2x; conservative bound selected.

Top-down narrows analyst TAM by geography and willingness-to-pay filters to $180M; bottom-up applies addressable customer count at realistic subscription ARPU to reach $530M. Divergence driven by uncertain paid-penetration rate assumption.

SOM 3YR // SERVICEABLE OBTAINABLE MARKET

$14M

Year-3 capture of roughly 8% of conservative SAM, assuming 78,000 active subscribers at $180 blended annual revenue per user.

>Methodology

TAM TOP-DOWN

Verified Market Reports places the dementia GPS tracker market at $1.5B in 2024; DataIntelo estimates $450M; WiseGuy estimates $6.47B. The $6.47B figure appears to include adjacent elderly monitoring hardware well beyond dementia-specific devices. The $1.5B figure from Verified Market Reports is the most scope-consistent with this product and is used as the conservative top-down TAM. The broader Elderly Monitors market at $3.5B is excluded as it overstates the addressable segment.

Conservative analyst estimate for dementia GPS tracker market (2024) = $1.5B

TAM BOTTOM-UP

55 million people globally live with dementia (Straits Research, 2023). The Alzheimer's Association states more than 60% will wander, yielding 33 million individuals with a meaningful safety need. ARPU is modeled at $200 for year one: a $150 device amortized and roughly $50 in net subscription revenue in year one, which is conservative relative to GPS SmartSole at $359 device plus $360 annual service. Full penetration of this cohort produces the ceiling figure.

55M patients x 60% wandering rate = 33M units x $200 ARPU = $6.6B

SAM FILTERS

Three filters applied to the conservative $1.5B TAM. First, geography: North America holds 39.6% market share (Straits Research), and the EU27 dementia population is approximately 9M, together representing roughly 55% of global revenue opportunity, yielding $825M. Second, willingness-to-pay filter: device-plus-subscription products above $100 upfront face adoption barriers per NCBI evidence; roughly 40% of the caregiver market is estimated to have both awareness and budget, yielding $330M top-down SAM. Third, a 55% discount for institutional versus direct-to-consumer channel friction reduces further to $180M.

$1.5B x 55% geography x 40% willingness-to-pay x 55% channel discount = $182M (rounded to $180M); bottom-up: 33M x 55% x 3% x $180 = $534M (rounded to $530M)

SOM BUILD

A competent new entrant with a differentiated dementia-specific wearable targets the conservative SAM of $180M. Year 1: 0.5% share = $900K, roughly 5,000 devices with subscription attach. Year 2: 2% share = $3.6M, scaling via two or three pilot partnerships with memory-care networks. Year 3: 8% share = $14.4M, assuming one reimbursement or insurer arrangement closes. The 8% ceiling reflects five funded incumbents sharing roughly 42.7% of the market, per competitive evidence, leaving meaningful but not easy share available.

Year 3: $180M SAM x 8% capture = $14.4M; implied 78,000 subscribers x $185 blended ARPU = $14.4M

Competitors // Threat map

NameFundingPositioningThreat
AngelSenseVC-backed; investors include Impact First Investments and O.G. Venture PartnersReal-time GPS with non-removable sleeve, speakerphone alerts, and caregiver app designed explicitly for cognitive impairment at $35 per month subscription.Highest direct threat. Already occupies the dementia-specific positioning you intend and has institutional caregiver relationships that drive referrals.
Jiobit (Life360)Acquired by Life360, a publicly traded companyCompact, multi-use tracker at $130 device plus $132 annual service; not dementia-specific but benefits from Life360 brand scale and distribution.Moderate threat. Scale and price advantage, but generic positioning creates a gap a dementia-focused product can exploit.
GPS SmartSoleNot disclosed; appears bootstrapped or lightly funded based on company size signalsDiscreet shoe-insert GPS at $359 device plus $300 per year, specifically marketed to dementia wandering caregivers.Moderate threat. Novel form factor removes the device-removal problem, which is the core clinical headwind for wrist wearables.
Tranquil GPS WatchNot disclosedDementia-specific GPS watch with seven-day battery and waterproofing at $750 upfront; premium positioning in the category.Low to moderate threat. High upfront cost limits addressable buyer pool but signals that premium pricing is achievable for the right feature set.
Family1st Senior GPS TrackerNot disclosedValue-positioned wearable lanyard tracker at $21.95 per month targeting budget-conscious family caregivers.Low threat as a direct competitor but pressures the lower end of your pricing range and limits how far down-market you can profitably go.

Sources

  1. 01Verified Market Reports: Dementia GPS Tracker Market · Conservative top-down TAM anchor of $1.5B in 2024
  2. 02WiseGuy Reports: Dementia GPS Tracker Market · High-end top-down TAM bound of $6.47B, flagged as likely scope-inflated
  3. 03DataIntelo: Global Dementia GPS Tracker Market · Low-end analyst estimate of $450M used to establish TAM range floor
  4. 04Data Bridge Market Research: Global Elderly Monitors Market · Broader category context at $3.5B; excluded from TAM as out-of-scope
  5. 05Straits Research: Dementia Care Products Market · Global dementia patient count of 55 million and North America 39.6% market share
  6. 06IHME via HealthData.org: Global dementia cases set to triple by 2050 · Long-range patient growth trajectory to 153 million by 2050
  7. 07News-Medical: EU27 dementia prevalence 2025 · EU27 patient count of 9.07 million used in SAM geography filter
  8. 08SafeWise: GPS Trackers for Dementia Patients · Alzheimer's Association wandering rate statistic of 60%; Tranquil GPS Watch pricing
  9. 09SeniorSite: Best Wearable Tracking Devices for Dementia Patients 2025 · Jiobit and Tranquil GPS Watch device pricing anchors
  10. 10Caring.com: Tracking Devices for Dementia Patients · GPS SmartSole pricing: $359 device plus $274.95 per year service
  11. 11Caring Village: GPS Trackers Review · Typical cellular tracker pricing range: $100 to $400 device, $8 to $40 per month
  12. 12CBInsights: AngelSense company profile · AngelSense funding and investor details
  13. 13NCBI PMC: Barriers to wearable adoption in dementia care · Documented headwinds: cost, caregiver training, privacy concerns, resistance to adoption
  14. 14NCBI PMC: Wearables in dementia research adherence issues · Device adherence headwind: charging, consent fluctuation, caregiver burden
  15. 15Triage Health Law Blog: FDA regulatory posture on wearables · Regulatory tailwind and risk: FDA easing for wellness wearables but clinical-management features risk device classification
  16. 16GPSTracker247: Best GPS Trackers for Dementia Patients · Family1st Senior GPS Tracker subscription pricing of $21.95 per month
  17. 17Tracxn: Trackimo company profile · Trackimo founding, size, and pricing details

More filings

Browse all filings →

Size another idea